Skip to Content

iShares Biotechnology ETF IBB

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IBB

Will IBB outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

iShares Biotechnology ETF’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IBB

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 49.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Vertex Pharmaceuticals Inc

8.94 658.5 Mil
Healthcare

Regeneron Pharmaceuticals Inc

8.67 638.4 Mil
Healthcare

Amgen Inc

7.93 584.0 Mil
Healthcare

Gilead Sciences Inc

7.10 522.4 Mil
Healthcare

IQVIA Holdings Inc

4.14 304.5 Mil
Healthcare

Biogen Inc

3.22 236.7 Mil
Healthcare

Moderna Inc

2.94 216.1 Mil
Healthcare

Mettler-Toledo International Inc

2.58 189.6 Mil
Healthcare

Illumina Inc

2.26 166.1 Mil
Healthcare

Waters Corp

1.95 143.2 Mil
Healthcare